000 01532 a2200481 4500
005 20250512212530.0
264 0 _c19850327
008 198503s 0 0 eng d
022 _a0143-3180
024 7 _a10.1111/j.1365-2710.1984.tb01091.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMartini, N
245 0 0 _aSerum and sputum concentrations of azlocillin, cefoperazone and ceftazidime in patients with cystic fibrosis.
_h[electronic resource]
260 _bJournal of clinical and hospital pharmacy
_cDec 1984
300 _a303-9 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAzlocillin
_xblood
650 0 4 _aCefoperazone
_xblood
650 0 4 _aCeftazidime
_xblood
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aCystic Fibrosis
_xenzymology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aKinetics
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPseudomonas Infections
_xdrug therapy
650 0 4 _aSputum
_xenzymology
650 0 4 _abeta-Lactamases
_xanalysis
700 1 _aAgostini, M
700 1 _aBarlocco, G
700 1 _aBozzini, L
700 1 _aCastellani, L
700 1 _aMessori, A
700 1 _aScroccaro, G
700 1 _aMastella, G
773 0 _tJournal of clinical and hospital pharmacy
_gvol. 9
_gno. 4
_gp. 303-9
856 4 0 _uhttps://doi.org/10.1111/j.1365-2710.1984.tb01091.x
_zAvailable from publisher's website
999 _c6396220
_d6396220